parsifal-long: fulvestrant and palbociclib vs letrozole and palbociclib
Published 8 months ago • 295 plays • Length 2:56Download video MP4
Download video MP3
Similar videos
-
5:04
paloma-3: palbociclib and fulvestrant for hr-/her metastatic breast cancer
-
1:29
capitello-292: capivasertib, palbociclib, and fulvestrant for hr endocrine-resistant breast cancer
-
1:49
phase ib data capitello-292: capivasertib palbociclib fulvestrant in hr /her2- breast cancer
-
0:55
fulvestrant plus palbociclib in breast cancer
-
1:53
palbociclib & fulvestrant for breast cancer
-
5:34
engot-en3-nsgo/paleo: letrozole-palbociclib combination for endometrial cancer
-
1:10
palbociclib, pembrolizumab, and endocrine therapy in hr /her2- breast cancer
-
2:02
palbociclib combined with fulvestrant in relapsed metastatic hr /her2- breast cancer
-
1:45
real-world clinical outcomes in metastatic breast cancer patients treated with palbociclib
-
5:00
penelope-b: palbociclib with endocrine therapy in hr , her2-negative breast cancer
-
6:20
fulvestrant and palbociclib as first-line treatment for hr /her2- breast cancer
-
5:10
paloma-3: overall survival (os) with palbociclib plus fulvestrant in hr ,her2_ abc
-
3:05
overall survival with palbociclib plus fulvestrant
-
1:43
composite biomarkers predictive of palbociclib endocrine treatment benefit in early breast cancer
-
2:29
breast cancer: palbociclib in later lines
-
13:22
palbociclib and breast cancer
-
3:30
final results from pallas: adjuvant palbociclib in hr /her2- early breast cancer
-
2:46
preliminary data on op-1250 palbociclib in advanced/metastatic er /her- breast cancer
-
3:08
young-pearl: palbociclib plus exemestane and ofs in hr /her2- breast cancer